Protein for preterm infants: how much is needed? How much is enough? How much is too much?

William W Hay1, Patti Thureen1

  • 1Department of Pediatrics, Section of Neonatology, University of Colorado School of Medicine, Aurora, USA.

Insights

Preterm infants need more protein for optimal growth. Higher protein and amino acid intake supports better development and cognitive function in premature babies.

Area of Science:

  • Neonatal nutrition
  • Pediatric gastroenterology

Background:

  • Preterm infants often receive insufficient protein for adequate growth in early postnatal life.
  • This deficit can lead to growth restriction, particularly in lean body mass, by the time of term-equivalent age.
  • Meeting intrauterine growth rates requires significantly higher protein intake than commonly provided.

Purpose of the Study:

  • To review protein and amino acid requirements for optimal growth and development in preterm infants.
  • To highlight the role of protein intake in brain growth and cognitive function.
  • To discuss evidence supporting increased protein and amino acid nutrition.

Main Methods:

  • Literature review of studies on protein and amino acid requirements in preterm infants.
  • Analysis of data on protein balance in response to varying nutritional interventions.
  • Examination of the relationship between neonatal nutrition and long-term outcomes.

Main Results:

  • Protein requirements are high in early preterm infants (up to 4 g/kg/day at 24-30 weeks' gestation), decreasing towards term.
  • Adequate protein intake is crucial for cellular function, protein synthesis, and overall development.
  • Increased protein and amino acid provision has been shown to improve protein balance in preterm infants, with benefits observed up to 4 g/kg/day.

Conclusions:

  • Preterm infants require substantially higher protein and amino acid intake than typically provided to support normal growth and development.
  • Optimizing protein and amino acid nutrition is critical for brain development and cognitive outcomes.
  • Further research is needed to establish optimal intravenous and enteral feeding strategies for preterm infants.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Proteins: Dietary Sources and Requirements01:28

Proteins: Dietary Sources and Requirements

Consuming animal-based products offers high-quality proteins that contain optimal levels and combinations of essential amino acids, crucial for tissue repair and growth. Foods like eggs, milk, fish, and most meats are a source of complete proteins. Legumes and cereals are abundant in proteins; however, they typically lack a full range of essential amino acids. As a result, they are considered incomplete protein sources. Some plant sources like soybeans, quinoa, and amaranth do contain complete...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...